Prostate Cancer Clinical Trial
Metabolomic Study for Localized Prostate Cancer
Summary
Prostate cancer is a common disease in men treated using surgery, radiation therapy and/or hormonal therapy. Clinical prognosis relates to stage and grade of disease. Recent advances in omic analysis may offer additional information to the physician about prognosis and radiation response. We propose to establish a protocol to incorporate omic analysis into the evaluation and treatment of patients with prostate cancer.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Males who are older than 18 years old,
with clinically localized prostate cancer
are receiving radiation therapy
Exclusion Criteria:
none
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
Georgetown University Hospital
Arlington Virginia, 22209, United States
Arlington Virginia, 22209, United States
How clear is this clinincal trial information?
